This collection of nineteen articles on Hepatitis C showcases state-of-the-art research and highlights new avenues for understanding and treating this dangerous liver disease. Beginning with an overview of the life cycle of the Hepatitis C virus (HCV), topics discussed include animal models for HCV research, accessing public resources for HCV research, drug clinical trial design, protease covalent and non-covalent inhibitors, NS5A inhibitors and examining innate immunity for HCV antiviral therapies. Intended for research scientist, papers include sample data and illustrations as well as voluminous reference material. Contributors include academics and researchers from a variety of universities, laboratories and pharmaceutical companies in the United States, Europe, Australia and Japan. Distributed in the US by ISBS. Annotation ©2011 Book News, Inc., Portland, OR (booknews.com)
